Published in TZ Latest News
3 November, 2017 by The TZ Newswire Staff
Ainsling Capital Raises $280M For Latest Life Sciences Fund
New York-based life sciences private equity company Aisling Capital has raised $280 million capital commitments for its latest fund to focus on bringing breakthrough medical treatments to market.